ENERGIZE THE FIGHT.
Our Mito Champions
Need to Connect with Us?
Call the Support Line: (888) 900-6486
Ask Congress to review the FDA’s decision not to approve elamipretide for Barth Syndrome and encourage thorough review and reform of the FDA’s rare disease therapy evaluation process
June Newsletter: FDA News, accelerators Finalists, Mito Med 2025, and More
Signup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup.
Learn More about PRMRP Mito Research Opportunities for FY25; Pre-applications Due June 9
The U.S. Department of Defense's Peer Reviewed Medical Research Program (PRMRP), established in 1999, has supported research across the full range of science and medicine, with an underlying goal of enhancing the health, care, and well-being of military service...